Intravesical application of a stable oxybutynin solution improves therapeutic compliance and acceptance in children with neurogenic bladder dysfunction

Journal of Urology

Volumn 160, Issue 3 II, 1998, Pages 1084-1087

  Buyse, Gunnar ^a   Verpoorten, Carla ^a   Vereecken, Raoul ^a   Casaer, Paul ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Bladder; Drug therapy; Pharmacology; Urodynamics

Indexed keywords

OXYBUTYNIN;

ADULT; AGED; BLADDER CAPACITY; BLADDER PRESSURE; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MALE; NEUROGENIC BLADDER; ORAL DRUG ADMINISTRATION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT OUTCOME; URODYNAMICS;

EID: 0032323310     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62703-4     Document Type: Conference Paper

References (18)

1. Baskin, L. S., Kogan, B. A. and Benard, F.: Treatment of infants with neurogenic bladder dysfunction using anticholinergic drugs and intermittent catheterisation. Brit. J. Urol., 66: 532, 1990.
2. Bauer, S. B. and Joseph, D. B.: Management of the obstructed urinary tract associated with neurogenic bladder dysfunction. Urol. Clin. N. Amer., 17: 395, 1990.
3. Fernandes, E. T., Reinberg, Y., Vernier, R. and Gonzales, R.: Neurogenic bladder dysfunction in children: review of pathophysiology and current management. J Fed., 124: 1, 1994.
4. Brendler, C. B., Radebaugh, L. C. and Mohler, J. L.: Topical oxybutynin chloride for relaxation of dysfunctional bladders. J. Urol., 141: 1350, 1989.
5. Greenfield, S. P. and Fera, M.: The use of intravesical oxybutynin chloride in children with neurogenic bladders. J. Urol., 146: 532, 1991.
6. Madersbacher, H. and Jilg, G.: Control of detrusor hyperreflexia by the intravesical instillation of oxybutynin hydrochloride. Paraplegia, 29: 84, 1991.
7. Kasabian, N. G., Vlachiotis, J. D., Lais, A., Klumpp, B., Kelly, M. D., Siroky, M. B. and Bauer, S. B.: The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia. J. Urol., 151: 944, 1994.
8. Buyse, G., Verpoorten, C., Vereecken, R. and Casaer, P.: Treatment of neurogenic bladder dysfunction in infants and children with neurospinal dysraphism with clean intermittent (self) catheterisation and optimized intravesical oxybutynin hydrochloride therapy. Eur. J. Pedr. Surg., suppl., 5: 31, 1995.
9. Painter, K. A., Vates, T. S., Bukowski, T. P., Fleming, P., Freedman, A. L., Smith, C. A., Gonzales, R. and Perlmutter, A. D.: Long-term intravesical oxybutynin chloride therapy in children with myelodysplasia. J. Urol., 156: 1459, 1996.
10. Connor, J. P., Betrus, G., Fleming, P., Perlmutter, A. D. and Reitelman, C.: Early cystometrograms can predict the response to intravesical instillation of oxybutynin chloride in myelomeningocele patients. J. Urol., 151: 1045, 1994.
11. Palmer, L. S., Zebold, K., Firlit, C. F. and Kaplan, W. E.: Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population. J. Urol., 157: 638, 1997
12. Hernandez, R. D., Hurwitz, R. S., Foote, J. E., Zimmern P. E. and Leach G. E.: Nonsurgical management of threatened upper urinary tracts and incontinence in children with myelomeningocele. J. Urol., 152: 1582, 1994.
13. Mizunaga, M., Miyata, M., Kaneko, S., Yachiku, S and Chiba, K.: Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder. Paraplegia, 32: 25, 1994.
14. Hjälmås, K.: Micturition in infants and children with normal lower urinary tract. A urodynamic study. Scand. J. Urol. Nephrol., 37: 1, 1976.
15. Houle, A. M., Gilmour, R. F., Churchill, B. M., Gaumond, M. and Bissonnette, B.: What volume can a child normally store in the bladder at a safe pressure? J. Urol., 149: 561, 1993.
16. Buyse, G., Waldeck, K., Verpoorten, C., Björk, H., Casaer, P., and Andersson, K-E.: Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism J. Urol., in press.
17. Aaltonen, L., Allonen, H., Iisalo, E., Juhakoski, A., Kleimola T. and Sellman, R.: Antimuscarinic activity of oxybutynin in the human plasma quantitated by a radioreceptor assay. Acta Pharmacol. Toxicol., 55: 100, 1984.
18. Waldeck K., Larsson, B. and Andersson, K. E.: Comparison of oxybutynin and its active metabolite N-desethy-oxybutynin, in the human detrusor and parotid gland. J. Urol., 157: 1093, 1997.